第 1 到 33 筆結果,共 33 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2017 | MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells | Lin S.-R.; Yeh H.-C.; Wang W.-J.; Ke H.-L.; Lin H.-H.; Hsu W.-C.; Chao S.-Y.; Hour T.-C.; Wu W.-J.; YEONG-SHIAU PU ; Huang A.-M. | Journal of Cellular Biochemistry | 30 | 29 | |
2 | 2017 | Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population | Lin Y.-C.; Hour T.-C.; YU-CHIEH TSAI ; Huang S.-P.; Wu W.-J.; CHUNG-HSIN CHEN ; YEONG-SHIAU PU ; Chung S.-D.; CHAO-YUAN HUANG | Urologic Oncology: Seminars and Original Investigations | 11 | 10 | |
3 | 2015 | EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1) | Hour T.-C.; Chung S.-D.; Kang W.-Y.; Lin Y.-C.; Chuang S.-J.; Huang A.-M.; Wu W.-J.; Huang S.-P.; CHAO-YUAN HUANG ; YEONG-SHIAU PU | Archives of Toxicology | 44 | 38 | |
4 | 2014 | Anti-cancer effects of ursane triterpenoid as a single agent and in combination with cisplatin in bladder cancer | Lin K.-W.; Huang A.-M.; Lin C.-C.; Chang C.-C.; Hsu W.-C.; Hour T.-C.; YEONG-SHIAU PU ; Lin C.-N. | European Journal of Pharmacology | 19 | 15 | |
5 | 2014 | Involvement of p38 mitogen-activated protein kinase in acquired gemcitabine-resistant human urothelial carcinoma sublines | Kao Y.-T.; Hsu W.-C.; Hu H.-T.; Hsu S.-H.; Lin C.-S.; Chiu C.-C.; Lu C.-Y.; Hour T.-C.; YEONG-SHIAU PU ; Huang A.-M. | Kaohsiung Journal of Medical Sciences | 11 | 10 | |
6 | 2012 | Cytotoxic and antioxidant constituents from Garcinia subelliptica | Lin K.-W.; Huang A.-M.; Yang S.-C.; Weng J.-R.; Hour T.-C.; YEONG-SHIAU PU ; Lin C.-N. | Food Chemistry | 31 | 26 | |
7 | 2011 | UBE2M-mediated p27Kip1 degradation in gemcitabine cytotoxicity | Huang A.-M.; Kao Y.-T.; Toh S.; Lin P.-Y.; Chou C.-H.; Hu H.-T.; Lu C.-Y.; Liou J.-Y.; Chao S.-Y.; Hour T.-C.; YEONG-SHIAU PU | Biochemical Pharmacology | 14 | 12 | |
8 | 2011 | Xanthine oxidase inhibitory triterpenoid and phloroglucinol from guttiferaceous plants inhibit growth and induced apoptosis in human ntub1 cells through a ROS-dependent mechanism | Lin K.-W.; Huang A.-M.; Tu H.-Y.; Lee L.-Y.; Wu C.-C.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | Journal of Agricultural and Food Chemistry | 29 | 29 | |
9 | 2011 | Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells | Tu H.-Y.; Huang A.-M.; Teng C.-H.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | Bioorganic and Medicinal Chemistry | 19 | 16 | |
10 | 2011 | Antioxidant xanthone derivatives induce cell cycle arrest and apoptosis and enhance cell death induced by cisplatin in NTUB1 cells associated with ROS | Cheng J.-H.; Huang A.-M.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | European Journal of Medicinal Chemistry | 42 | 41 | |
11 | 2011 | 18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells | Lin K.-W.; Huang A.-M.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | Bioorganic and Medicinal Chemistry | 39 | 37 | |
12 | 2010 | Transcriptional up-regulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cells | Hour T.-C.; Lai Y.-L.; Kuan C.-I.; Chou C.-K.; Wang J.-M.; Tu H.-Y.; Hu H.-T.; Lin C.-S.; Wu W.-J.; YEONG-SHIAU PU ; Sterneck E.; Huang A.-M. | Biochemical Pharmacology | 55 | 56 | |
13 | 2010 | Terpenoids induce cell cycle arrest and apoptosis from the stems of Celastrus kusanoi associated with reactive oxygen species | Chen H.-L.; Lin K.-W.; Huang A.-M.; Tu H.-Y.; Wei B.-L.; Hour T.-C.; Yen M.-H.; YEONG-SHIAU PU ; Lin C.-N. | Journal of Agricultural and Food Chemistry | 25 | 20 | |
14 | 2010 | Xanthine oxidase inhibitory terpenoids of Amentotaxus formosana protect cisplatin-induced cell death by reducing reactive oxygen species (ROS) in normal human urothelial and bladder cancer cells | Lin C.-N.; Huang A.-M.; Lin K.-W.; Hour T.-C.; Ko H.-H.; Yang S.-C.; YEONG-SHIAU PU | Phytochemistry | 18 | 14 | |
15 | 2010 | Synthesis and biological evaluation of 2′,5′-dimethoxychalcone derivatives as microtubule-targeted anticancer agents | Tu H.-Y.; Huang A.-M.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | Bioorganic and Medicinal Chemistry | 29 | 28 | |
16 | 2010 | Ling-zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells | CHAO-YUAN HUANG ; Chen J.Y.-F.; Wu J.-E.; YEONG-SHIAU PU ; Liu G.-Y.; Pan M.-H.; Huang Y.-T.; Huang A.-M.; Hwang C.-C.; Chung S.-J.; Hour T.-C. | Journal of Agricultural and Food Chemistry | 44 | 38 | |
17 | 2009 | Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma | YEONG-SHIAU PU ; CHAO-YUAN HUANG ; Kuo Y.-Z.; Kang W.-Y.; Liu G.-Y.; Huang A.-M.; HONG-JENG YU ; Lai M.-K.; Huang S.-P.; Wu W.-J.; Chiou S.-J.; Hour T.-C. | Journal of Biomedical Science | 31 | 29 | |
18 | 2009 | Phloroglucinols Inhibit Chemical Mediators and Xanthine Oxidase, and Protect Cisplatin-Induced Cell Death by Reducing Reactive Oxygen Species in Normal Human Urothelial and Bladder Cancer Cells | Lin K.-W.; Huang A.-M.; Tu H.-Y.; Weng J.-R.U.; Hour T.-C.; Wei B.-L.; Yang S.-C.; Wang J.-P.; YEONG-SHIAU PU ; Lin C.-N. | Journal of Agricultural and Food Chemistry | 11 | 11 | |
19 | 2009 | Ursolic acid derivatives induce cell cycle arrest and apoptosis in NTUB1 cells associated with reactive oxygen species | Tu H.-Y.; Huang A.-M.; Wei B.-L.; Gan K.-H.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | Bioorganic and Medicinal Chemistry | 83 | 74 | |
20 | 2009 | Down regulation of ABCD1 in human renal cell carcinoma | Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Wu W.-J.; Huang S.-P.; YEONG-SHIAU PU | International Journal of Biological Markers | 9 | 9 | |
21 | 2008 | Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma | Liu C.-H.; Huang J.-D.; Huang S.-W.; Hour T.-C.; Huang Y.-K.; Hsueh Y.-M.; Chiou H.-Y.; Lee T.-C.; Jan K.-Y.; Chen C.-J.; YEONG-SHIAU PU | Journal of Biomedical Science | 12 | 9 | |
22 | 2008 | Down-regulated expression of RhoA in human conventional renal cell carcinoma | YEONG-SHIAU PU ; Wang C.-W.; Liu G.-Y.; Kuo Y.-Z.; CHAO YUAN HUANG ; Kang W.-Y.; CHIA-TUNG SHUN ; CHIA-CHI LIN ; Wu W.-J.; Hour T.-C. | Anticancer Research | 5 | 5 | |
23 | 2007 | Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial | CHIA-CHI LIN ; CHIH-HUNG HSU ; Hour T.-C.; ANN-LII CHENG ; CHAO-YUAN HUANG ; KUO-HOW HUANG ; Chen J.; YEONG-SHIAU PU | Urologic Oncology: Seminars and Original Investigations | 6 | 6 | |
24 | 2006 | Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer | Hour T.-C.; YEONG-SHIAU PU ; CHIA-CHI LIN ; SHI-WEI HUANG ; Chen J.; Chiu A.W.; Chen C.-J.; CHAO-YUAN HUANG | Anticancer Research | 10 | 8 | |
25 | 2006 | Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells | YEONG-SHIAU PU ; Hsieh M.-W.; Wang C.-W.; Liu G.-Y.; CHAO-YUAN HUANG ; CHIA-CHI LIN ; Guan J.-Y.; Lin S.-R.; Hour T.-C. | Biochemical Pharmacology | 38 | 35 | |
26 | 2005 | Resistance to paclitaxel is proportional to cellular total antioxidant capacity | Ramanathan B.; Jan K.-Y.; Chen C.-H.; Hour T.-C.; HONG-JENG YU ; YEONG-SHIAU PU | Cancer Research | 245 | 231 | |
27 | 2004 | Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide | Hour T.-C.; CHAO-YUAN HUANG ; CHIA-CHI LIN ; Chen J.; Guan J.-Y.; Lee J.-M.; YEONG-SHIAU PU | Anti-Cancer Drugs | 24 | 23 | |
28 | 2004 | Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells | YEONG-SHIAU PU ; Hour T.-C.; Chuang S.-E.; ANN-LII CHENG ; Lai M.-K.; Kuo M.-L. | Prostate | 70 | 71 | |
29 | 2002 | Arsenic trioxide as a novel anticancer agent against human transitional carcinoma - Characterizing its apoptotic pathway | YEONG-SHIAU PU ; Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H. | Anti-Cancer Drugs | 57 | 48 | |
30 | 2002 | Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBPβ expressions and suppressing NF-κB activation | Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H.; YEONG-SHIAU PU | Prostate | 125 | 110 | |
31 | 2002 | Cytotoxicity of arsenic trioxide to transitional carcinoma cells | YEONG-SHIAU PU ; Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H. | Urology | 25 | 32 | |
32 | 2001 | Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells | YEONG-SHIAU PU ; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H.; Hour T.-C. | Journal of Urology | 20 | 18 | |
33 | 2000 | Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines | Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H.; CHANG-YAO HSIEH ; YEONG-SHIAU PU | Anticancer Research | 45 | 40 |